Anti-Obesity Drugs Market is expected to reach US$ 5.17 Bn by 2029 from US$ 1.93 Bn in 2022, at a CAGR of 15.1% during the forecast period. Global Anti-Obesity Prescription Drugs Market Over… Read More

The post Anti-Obesity Drugs Market Statistics and Industry Analysis 2029 appeared first on Newstrail.com authored by Maximize Market Research Anti-Obesity Drugs Market Overview The… Read More

The Anti-Obesity Drugs Market is destined to grow on an impertinent note, i.e. reaching 2X at a CAGR of XX% between 2015-2025. Personalization has taken over almost every sphere of… Read More

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Obesity pipeline constitutes 100+ key companies continuously working towards developing 130+ Obesity tr… Read More

weight loss Continuous glucose monitoring (CGM) offered little useful information for dietary choices among patients without diabetes, a researcher reported. In a 23-person study of those… Read More

weight loss Beyond weight loss, bariatric surgery was also effective at improving vascular outcomes, a new study found. In a study of more than 300 adults with obesity, there was an avera… Read More

Glancy Prongay & Murray LLP (GPM) announces an investigation on behalf of Zafgen, Inc. (Zafgen Read More

DBMR added a new research report on Global Weight Loss and Obesity Management Market 2021 by Top players, Regions, Type and Application, Forecast to 2027 report provides a credible W… Read More

BOSTON, Oct. 12, 2017 (GLOBE NEWSWIRE) — Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company dedicated to significantly improving the health and well-being of patien… Read More

( click to enlarge )Myovant Sciences Ltd (NYSE:MYOV) is getting again some buying and looks poised to post some big gains if the buying volume persists. A break above $14.60 with conviction… Read More

( click to enlarge )Fuwei Films (Holdings) Co Ltd (NASDAQ: FFHL) Here is a great stock that I find worth considering for your watchlist after a big pullback on low volume in its value during… Read More

( click to enlarge )Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) broke out into the gap area with heavy volume on Friday and I expect a continuation of the move that started last week. The MA… Read More